
Overview
Jecture Poland is part of Jecture, a company formed by the merger of Acti-Med and Europin, which develops and manufactures high-precision cannulas and cannula systems for regulated MedTech and pharmaceutical markets, including combination products. Its European sites in Germany, Poland and Slovakia follow harmonized processes to deliver consistent quality and scalable production of approved products. The portfolio covers liquid drug delivery, infusion and vascular access, diagnostics and sampling, and inhalation applications.
Financials
Revenue history (in m)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 133 days for 2021). All were audited by a statutory auditor.
- 202522/06/2026
- 202414/07/2025
- 202320/06/2024
- 202224/10/2023
- 202125/11/2022
- 202027/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Sustainability Report
Explore the Jecture Sustainability Report 2025 and learn more about our progress in environmental, social and governance topics

A shared long-term perspective
What makes this partnership particularly meaningful is that it is only possible because many of our globally operating customers have also chosen to enter into long-term agreements with the Jecture Group. This creates a sustainable partnership model in which customers, suppliers, and Jecture share the same long-term perspective. Instead of simply reacting to market volatility, […]

One magazine. Three locations. One JECTURE team.
On 16 July, we proudly distributed the very first edition of the “INJecture” Magazine across all three JECTURE plants. For the first time, the individual site magazines from our facilities have been brought together into one unified publication – creating a single platform to share the people, projects, achievements, and ideas that shape our company […]

75 years of combined experience
75years of combined Experience – Three plants – One strong partner for MedTech Manufacturing For more than 25 years, the companies that now form JECTURE have supported customers in the medical technology industry with precision manufacturing, engineering expertise, and reliable production processes. The merger of Acti-Med and Europin brought together decades of know-how, complementary capabilities, […]
Industry
Offer
- Medical cannulas
- Cannula systems
- Precision cannulas
- Components for medical devices
Websites
The site is available in: English and German.
- jecture.comJecture – The Cannula ExpertsWooCommerceWordPress 7.1ElementorGoogle AnalyticsGoogle Tag ManagerYoast SEONginx
Job offers
The company lists 2 job openings on its own careers page: jecture.com/careers-in-medical-technology-jecture.
Authorized Representatives
Manner of representation
Each member of the management board will have the right to make declarations and sign on behalf of the company, acting independently and without limitations in relation to third parties
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Acti-med Gmbh | 9,204 | $124,311.18 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2013-01-01.
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 79,815PLN 79,815 |
Public aid
4 public aid cases recorded, with a total value of $35,258.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 5, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Starosta Powiatu Grodziskiego | |
| Apr 15, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Apr 21, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Waste generation | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Inmed S.A. | $13,860,648.96 | inmed.pl | ||
| Sinmed sp. z o.o. | $12,600,321.64 | sinmed.pl | ||
| SUMI sp. z o.o. + limited partnership | $11,618,230.43 | sumi.com.pl | ||
| Carnamedica sp. z o.o. | $10,629,942.92 | carnamedica.com | ||
| Poldent sp. z o.o. | $9,440,759.21 | poldent.pl | ||
| Extrudan sp. z o.o. | $8,241,066.38 | extrudan.com | ||
| Zakład Techniki Medycznej Tech-Med sp. z o.o. | $7,640,728.17 | technikawmedycynie.pl | ||
| Margomed S.A. | $6,360,594.28 | margomed.com | ||
| Hagmed sp. z o.o. + limited partnership | $5,900,892.99 | hagmed.com | ||
| Advance Europe Biuro Techniczno - Handlowe sp. z o.o. | $2,781,347.45 | advanceeurope.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-14 | Name change ("acti-Med Polska" → Jecture Poland) | |
| 2025-11-14 | Switch to PKD 2025 (6 PKD 2007 codes → 6 PKD 2025 codes) | |
| 2019-03-15 | Address change (Al. Jerozolimskie 475, 05-802, Pruszków → Ul. Gen. G. Orlicz-Dreszera 31a, 05-825, Kozerki) | |
| 2018-06-05 | PKD change (Removed: 46.69.Z; Added: 68.20.Z, 71.20.B, 72.19.Z, 74.90.Z, 82.92.Z) | |
| 2014-05-07 | Share capital increase (169,400.00 PLN → 460,200.00 PLN) |
FAQ
Last updated: 2026-11-12
